Doximity Net Income/Loss 2020-2025 | DOCS

Doximity annual/quarterly net income/loss history and growth rate from 2020 to 2025. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
  • Doximity net income/loss for the quarter ending March 31, 2025 was $0.223B, a 51.23% increase year-over-year.
  • Doximity net income/loss for the twelve months ending March 31, 2025 was $0.511B, a 49.38% increase year-over-year.
  • Doximity annual net income/loss for 2025 was $0.223B, a 51.23% increase from 2024.
  • Doximity annual net income/loss for 2024 was $0.148B, a 30.81% increase from 2023.
  • Doximity annual net income/loss for 2023 was $0.113B, a 27.11% decline from 2022.
Doximity Annual Net Income/Loss
(Millions of US $)
2025 $223
2024 $148
2023 $113
2022 $155
2021 $50
2020 $30
2019 $8
Sector Industry Market Cap Revenue
Medical Medical Information Systems $11.290B $0.570B
Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.130B 58.69
Hims & Hers Health (HIMS) United States $11.277B 117.16
Tempus AI (TEM) United States $10.557B 0.00
IRhythm Technologies (IRTC) United States $4.350B 0.00
Inspire Medical Systems (INSP) United States $3.741B 58.45
Hinge Health (HNGE) United States $3.664B 0.00
Privia Health (PRVA) United States $2.391B 163.42
Schrodinger (SDGR) United States $1.574B 0.00
Phreesia (PHR) United States $1.516B 0.00
Enovis (ENOV) United States $1.502B 8.37
Clover Health Investments (CLOV) United States $1.496B 0.00
10x Genomics (TXG) United States $1.496B 0.00
Azenta (AZTA) United States $1.427B 66.30
Omnicell (OMCL) United States $1.259B 22.22
Evolent Health (EVH) United States $1.119B 95.30
Claritev (CTEV) United States $0.702B 0.00
Fulgent Genetics (FLGT) United States $0.541B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.467B 0.00
Butterfly Network (BFLY) United States $0.462B 0.00
Talkspace (TALK) United States $0.415B 124.00
TruBridge (TBRG) United States $0.336B 746.33
Outset Medical (OM) United States $0.309B 0.00
Nyxoah SA (NYXH) Belgium $0.280B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
CapsoVision (CV) United States $0.211B 0.00
Zepp Health (ZEPP) Netherlands $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.155B 0.00
Pulmonx (LUNG) United States $0.127B 0.00
American Well (AMWL) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.114B 0.00
CareCloud (CCLD) United States $0.101B 3.85
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.079B 0.00
111 (YI) China $0.066B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00